Cited by 307Diabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid MetabolismAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 113 of the 114 references it cites were found in a registry or an index.

The emerging role of HDL in glucose metabolism

Drew, Brian G., Rye, Kerry-Anne, Duffy, Stephen J., Barter, Philip, Kingwell, Bronwyn A.·2012·Nature Reviews Endocrinology

DOI 10.1038/nrendo.2011.235

Open this paper in CoChat — free account

Abstract

A low plasma level of HDL cholesterol is an atherosclerotic risk factor; however, emerging evidence suggests that low HDL levels might also contribute to the pathophysiology of type 2 diabetes mellitus (T2DM) through direct effects on plasma glucose. In the past decade, animal and clinical studies have uncovered a previously undescribed spectrum of HDL actions, indicating that HDL may control glucose homeostasis through mechanisms including insulin secretion, direct glucose uptake by muscle via the AMP-activated protein kinase, and possibly enhanced insulin sensitivity. These effects are mediated by multiple cell types via mechanisms including preservation of cell function through cellular lipid removal and also via direct signaling events. We suggest a paradigm shift from HDL being a bystander to being an active player in diabetic pathophysiology, which raises the possibility that HDL elevation could be a novel therapeutic avenue for T2DM. The entry of HDL-raising agents of the cholesteryl ester transfer protein (CETP) inhibitor class into late-phase clinical trials creates potential for rapid clinical translation. This Review will discuss the emerging evidence for a role of HDL-mediated glucose regulation in the pathophysiology of T2DM, and will also outline the therapeutic potential for HDL elevation for the prevention and management of T2DM.

Integrity signals

Registry

Crossref · 10.1038/nrendo.2011.235

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67667-2 · Cited by 3,284
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943

Flagged first, then by citations

Show all 114 references

1 of the 114 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 307

Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease
Stadler, J. T., Wadsack, C., & Marsche, G. (2021) · Biomedicines · doi:10.3390/biomedicines9040349 · Cited by 25
Causal Graph Among Serum Lipids and Glycemic Traits: A Mendelian Randomization Study
Zhu, Z., Wang, K., Hao, X., Chen, L., Liu, Z., & Wang, C. (2022) · Diabetes · doi:10.2337/db21-0734 · Cited by 26
High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties
Klančič, T., Woodward, L., Hofmann, S. M., & Fisher, E. A. A. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.03.001 · Cited by 29
Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: The prospective cohort PREVEND study
Kunutsor, S. K., Kieneker, L. M., Bakker, S. J. L., James, R. W., & Dullaart, R. P. F. (2017) · Metabolism · doi:10.1016/j.metabol.2017.05.004 · Cited by 26
Association of TG / HDLC ratio trajectory and risk of type 2 diabetes: A retrospective cohort study in China
Zhang, Y., Qin, P., Lou, Y., Zhao, P., Li, X., Qie, R., Wu, X., Han, M., Huang, S., Zhao, Y., et al. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13123 · Cited by 25
The role of Krüppel-like factor 14 in the pathogenesis of atherosclerosis
Xie, W., Li, L., Zheng, X., Yin, W., & Tang, C. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.011 · Cited by 25
Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
Matikainen, N., & Taskinen, M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0309-3 · Cited by 24
Hepatitis B virus infection and diabetes mellitus: the Kailuan prospective cohort study in China
Lei, S., Chen, S., Zhao, X., Zhang, Y., Cheng, K., Zhang, X., Wang, Z., Sun, Y., Wu, S., & Wang, L. (2020) · Hepatology International · doi:10.1007/s12072-020-10086-2 · Cited by 24
Cholesteryl Ester Transfer Protein Genetic Variants Associated with Risk for Type 2 Diabetes and Diabetic Kidney Disease in Taiwanese Population
Huang, Y., Chen, S., Liu, S., Lin, J.-M., Lin, H., Lei, Y.-J., Chung, Y. E., Chen, Y., Wang, Y., Liao, W., et al. (2019) · Genes · doi:10.3390/genes10100782 · Cited by 22
Ambient air pollution exposure, plasma metabolomic markers, and risk of type 2 diabetes: A prospective cohort study
Xu, H. Y., Xu, H., Wu, J., Wang, L., Guo, B., Li, W., Zhang, J., Xiao, X., & Zhao, X. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132844 · Cited by 21
Association of TNF-α polymorphisms (−857, −863 and −1031), TNF-α serum level and lipid profile with acne vulgaris
Younis, S., Shamim, S., Nisar, K., Deeba, F., Mehmood, S., Mumtaz, S., Blumenberg, M., & Javed, Q. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.042 · Cited by 21
Association between metabolic syndrome, insulin resistance, and IGF-1 in breast cancer survivors of DIANA-5 study
Santi, M. D., Annibalini, G., Marano, G., Biganzoli, G., Venturelli, E., Pellegrini, M., Lucertini, F., Brandi, G., Biganzoli, E. M., Barbieri, E., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04755-6 · Cited by 21
Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma
Wang, Y., Chen, S., Xiao, X., Yang, F., Wang, J., Zong, H., Gao, Y., Huang, C., Xu, X., Fang, M., et al. (2023) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbad021 · Cited by 21
High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?
Liu, K., Cooper, M. E., Chai, Z., & Liu, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041683 · Cited by 20
Low high‐density lipoprotein cholesterol level is a significant risk factor for development of type 2 diabetes: Data from the H awaii– L os A ngeles– H iroshima study
Hirano, M., Nakanishi, S., Kubota, M., Maeda, S., Yoneda, M., Yamane, K., Kira, S., Sasaki, H., & Kohno, N. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12170 · Cited by 20
Apolipoprotein CIII and diabetes. Is there a link?
Christopoulou, E. C., Tsimihodimos, V., Filippatos, T. D., & Elisaf, M. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3118 · Cited by 21
ABCA12 regulates insulin secretion from β‐cells
Ursino, G., Fu, Y., Cottle, D. L., Mukhamedova, N., Jones, L. K., Low, H., Tham, M. S., Gan, W. J., Mellett, N. A., Das, P. P., et al. (2020) · EMBO Reports · doi:10.15252/embr.201948692 · Cited by 19
Non-linear relationship between high-density lipoprotein cholesterol and incident diabetes mellitus: a secondary retrospective analysis based on a Japanese cohort study
Cao, C., Hu, H., Zheng, X., Zhang, X., Wang, Y., & He, Y. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01074-8 · Cited by 19
CETP Inhibitors: Should We Continue to Pursue This Pathway?
Nicholls, S. J., & Nelson, A. J. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01070-2 · Cited by 19
Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians
Nair, A. K., Piaggi, P., McLean, N. A., Kaur, M., Kobes, S., Knowler, W. C., Bogardus, C., Hanson, R. L., & Baier, L. J. (2015) · Diabetologia · doi:10.1007/s00125-015-3835-x · Cited by 19
Can we revive CETP-inhibitors for the prevention of cardiovascular disease?
Nicholls, S. J., Ray, K. K., Nelson, A. J., & Kastelein, J. J. P. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000854 · Cited by 19
Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up
Jeong, H. S., Hong, S. J., Son, S., An, H., Kook, H., Joo, H. J., Park, J. H., Yu, C. W., & Lim, D. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0969-z · Cited by 18
Association between the atherogenic index of plasma and long-term risk of type 2 diabetes: a 12-year cohort study based on the Japanese population
Zhou, Q., Wu, Y., & Li, M. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02605-y · Cited by 18
Skeletal Muscle Insulin Resistance Associated with Cholesterol-Induced Activation of Macrophages Is Prevented by High Density Lipoprotein
Carey, A. L., Siebel, A. L., Reddy-Luthmoodoo, M., Natoli, A. K., D’Souza, W., Meikle, P. J., Sviridov, D., Drew, B. G., & Kingwell, B. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056601 · Cited by 18
Self-citation
Association between nontraditional lipid parameters and the risk of type 2 diabetes and prediabetes in patients with nonalcoholic fatty liver disease: from the national health and nutrition examination survey 2017–2020
Liu, J., Fu, Q., Su, R., Liu, R., Wu, S., Li, K., Wu, J., & Zhang, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1460280 · Cited by 18
A nomogram for predicting 5-year incidence of type 2 diabetes in a Chinese population
Lin, Z., Guo, D., Chen, J., & Zheng, B. (2019) · Endocrine · doi:10.1007/s12020-019-02154-x · Cited by 17
Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes
Kostara, C. E., Karakitsou, K. S., Florentin, M., Bairaktari, E. T., & Tsimihodimos, V. (2022) · Metabolites · doi:10.3390/metabo12080683 · Cited by 16
The Effects of Exercise Training on the Traditional Lipid Profile and Beyond
GORDON, B. L., Chen, S., & Durstine, J. L. (2016) · Translational Journal of the American College of Sports Medicine · doi:10.1249/tjx.0000000000000023 · Cited by 17
Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters
Briand, F., Prunet‐Marcassus, B., Thiéblemont, Q., Costard, C., Muzotte, E., Sordello, S., & Sulpice, T. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.028 · Cited by 17
Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients
Liao, W., Chen, Y., Gao, Q., Gan, R.-R., Li, M., Liu, Z., Liang, J., Cui, H., Ren, K., Liu, Y., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02061-6 · Cited by 18
Machine learning‐based clustering identifies obesity subgroups with differential multi‐omics profiles and metabolic patterns
Anwar, M. Y., Highland, H. M., Buchanan, V. L., Graff, M., Young, K., Taylor, K. D., Tracy, R. P., Durda, P., Liu, Y., Johnson, C. W., et al. (2024) · Obesity · doi:10.1002/oby.24137 · Cited by 17
The association between apolipoprotein M and insulin resistance varies with country of birth
Memon, A. A., Bennet, L., Zöller, B., Wang, X., Palmér, K., Dahlbäck, B., Sundquist, J., & Sundquist, K. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.05.007 · Cited by 16
Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
Cartolano, F. D. C., Dias, G. D. F., de Freitas, M. C. P., Neto, A. M. F., & Damasceno, N. R. T. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1018796 · Cited by 17
Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant
Dalla‐Riva, J., Lagerstedt, J. O., & Petrlová, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143915 · Cited by 16
Cholesteryl Ester Transfer Protein (CETP) expression does not affect glucose homeostasis and insulin secretion: studies in human CETP transgenic mice
Raposo, H. F., Vanzela, E. C., Berti, J. A., & Oliveira, H. C. F. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0179-6 · Cited by 15
The potential of the serum uric acid to high-density lipoprotein cholesterol ratio as a predictive biomarker of diabetes risk: a study based on NHANES 2005–2018
Yin, J., Zheng, C., Lin, X., Huang, C., Hu, Z., Lin, S., & Qu, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1499417 · Cited by 15
Peptide-based high-density lipoprotein promotes adipose tissue browning and restrains development of atherosclerosis and type 2 diabetes
Xu, R., Li, S., Shi, M., Li, Z., Wang, Y., Li, J., Li, Q., Klausen, L. H., Li, A., Zhao, H., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101054 · Cited by 15
Inflammaging and body composition: New insights in diabetic and hypertensive elderly men
Gonçalves, C. V., Ribeiro, I. S., Galantini, M. P. L., Muniz, I. P. R., Lima, P. H. B., dos Santos, G. G. A., & da Silva, R. A. A. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.112005 · Cited by 14
Effects of vitamin E administration on serum lipid profile in diabetic patients: a grade-assessed systematic review and dose–response meta-analysis of RCTs
Karimi, M., Karimi, M. A., Fayedeh, F., Kafi, F. Z., Kazemi, K., Jahangiri, S., & Asbaghi, O. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01833-2 · Cited by 16
The role of fibrinolysis in the development of prediabetes-associated coronary heart disease: a focus on the plasminogen activator inhibitor -1 and its potential use as a predictive marker in diet-induced prediabetes
Gumede, N. P., & Khathi, A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1256427 · Cited by 13
Gender differences in the association between the uric acid to high-density lipoprotein cholesterol ratio and diabetes risk: a mediation analysis of c-reactive protein, triglycerides, and insulin resistance
Yin, J., Zheng, C., Li, Z., Chang, Y., Cao, L., & Qu, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02404-6 · Cited by 13
Dysfunctional high-density lipoproteins in diabetes mellitus
Poteryaeva, O. N., & Федорович, У. И. (2022) · Problems of Endocrinology · doi:10.14341/probl13118 · Cited by 13
HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
Blanco-Rojo, R., Pérez‐Martínez, P., López-Moreno, J., Martínez-Botas, J., Delgado‐Lista, J., van-Ommen, B., Yubero‐Serrano, E. M., Camargo, A., Ordovás, J. M., Pérez‐Jiménez, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12678-9 · Cited by 13
Genetically Mediated Lipid Metabolism and Risk of Insulin Resistance: Insights from Mendelian Randomization Studies
Bu, S. Y. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.2.132 · Cited by 15
Genetic linkage of hyperglycemia and dyslipidemia in an intercross between BALB/cJ and SM/J Apoe-deficient mouse strains
Wang, Q., Grainger, A. T., Manichaikul, A. W., Farber, E., Önengüt-Gümüşcü, S., & Shi, W. (2015) · BMC Genetics · doi:10.1186/s12863-015-0292-y · Cited by 13
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART
Squillace, N., Lorenzini, P., Lapadula, G., Bandera, A., Cozzi‐Lepri, A., Rusconi, S., Puoti, M., Castagna, A., Antinori, A., Gori, A., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw185 · Cited by 12
Longitudinal trajectories of atherogenic index of plasma and risks of cardiovascular diseases: results from the Korean genome and epidemiology study
Chun, D.-W., Lee, Y.-J., Lee, J., & Lee, J. (2023) · Thrombosis Journal · doi:10.1186/s12959-023-00542-y · Cited by 12
HDL-C criterion of the metabolic syndrome and future diabetes and atherosclerosis in midlife women: The SWAN Study
Wang, Z., Barinas‐Mitchell, E., Brooks, M. M., Crawford, S. L., Leis, A. M., Derby, C. A., Thurston, R. C., Hedderson, M. M., Janssen, İ., Jackson, E. A., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100687 · Cited by 12
A U-shaped association between the triglyceride to high-density lipoprotein cholesterol ratio and the risk of incident type 2 diabetes mellitus in Japanese men with normal glycemic levels: a population-based longitudinal cohort study
Song, B., Wang, K., Lu, W., Zhao, X., Yao, T., Liu, T., Gao, G., Fan, H., & Liu, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1180910 · Cited by 12
High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
Sokooti, S., Szili‐Török, T., Flores-Guerrero, J. L., Osté, M. C. J., Neto, A. W. G., Kootstra‐Ros, J. E., Heerspink, H. J. L., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2020) · Biomolecules · doi:10.3390/biom10030481 · Cited by 12
Association between hs-CRP/HDL-C ratio and risk of prediabetes or diabetes: a cross-sectional study based on NHANES 2015–2023
Sun, H., Yang, J., Ma, L., & Wu, Y. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02004-0 · Cited by 14
Genetic Evidence for a Causal Relationship between Hyperlipidemia and Type 2 Diabetes in Mice
Shi, L. J., Tang, X., He, J., & Shi, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116184 · Cited by 11
The relationship between the ratio of gamma-glutamyltransferase to high-density lipoprotein cholesterol and the risk of diabetes mellitus using publicly available data: a secondary analysis based on a longitudinal study in Japan
Zhao, Y., Xin, X., & Luo, X. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01772-9 · Cited by 11
LC–MS-Based Metabolomics and Lipidomics Study of High-Density-Lipoprotein-Modulated Glucose Metabolism with an apoA-I Knockout Mouse Model
Liu, J., Zhao, M., Zhu, Y., Wang, X., Zheng, L., & Yin, Y. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00290 · Cited by 12
Efficacy and safety of obicetrapib in patients with dyslipidemia: An updated meta-analysis of randomized controlled trials
Araújo, B., Arrighini, G. S., Queiroga, F., Mansouri, E. S., Rivera, A., Amador, W. F. O., Queiroz, I., Akabane, M. A. C. C., Consoli, L. N., Sobral, M. V. S., et al. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101303 · Cited by 10
“Both experimental and clinical studies have shown that HDL directly enhances insulin sensitivity and glucose homeostasis, providing a plausible biological mechanism for the reduced incidence of diabetes observed with obicetrapib [34,35].”
Relation of four nontraditional lipid profiles to diabetes in rural Chinese H-type hypertension population
Wang, H., Guo, X., Chen, Y., Li, Z., Xu, J., & Sun, Y. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0590-7 · Cited by 10
PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study
Feng, X., Gao, X., Jia, Y., & Xu, Y. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0257-4 · Cited by 10
High‐density lipoprotein ‐cholesterol and incident type 2 diabetes mellitus among African Americans: The Jackson Heart Study
Agoons, D. D., Musani, S. K., Correa, A., Golden, S. H., Bertoni, A. G., & Echouffo-Tcheugui, J. B. (2022) · Diabetic Medicine · doi:10.1111/dme.14895 · Cited by 8
Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria
Solares, I., Jericó, D., Córdoba, K. M., Morales‐Conejo, M., Ena, J., de Salamanca, R. E., & Fontanellas, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010051 · Cited by 11
Association between CETP gene polymorphism, insulin resistance and risk of diabetes mellitus in patients with vascular disease
Koopal, C., van der Graaf, Y., Asselbergs, F. W., Westerink, J., & Visseren, F. L. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.015 · Cited by 10
Mapping and Congenic Dissection of Genetic Loci Contributing to Hyperglycemia and Dyslipidemia in Mice
Shi, W., Wang, Q., Choi, W., & Li, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148462 · Cited by 9
Prediction of Insulin Resistance in Nondiabetic Population Using LightGBM and Cohort Validation of Its Clinical Value: Cross-Sectional and Retrospective Cohort Study
Peng, T., Miao, R., Xiong, H., Yanhui, L., Fan, D., Ren, J., Wang, J., Li, Y., & Chen, J. (2025) · JMIR Medical Informatics · doi:10.2196/72238 · Cited by 8
Uncovering the role of apolipoprotein C-III in insulin resistance
Aguilar-Recarte, D., Palomer, X., & Vázquez‐Carrera, M. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.09.003 · Cited by 8
Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
Ardaiz, N., Gomar, C., Vásquez, M., Tenesaca, S., Fernández-Sendin, M., Trani, C. A. D., Belsúe, V., Escalada, J., Ulrich, W., Tennagels, N., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.591293 · Cited by 8
HDL-enriched miR-30a-5p is associated with HDL-cholesterol levels and glucose metabolism in healthy men and women
Clément, A., Desgagné, V., Légaré, C., Guay, S., Boyer, M., Hutchins, E. D., Corbin, F., Keuren‐Jensen, K. R. V., Arsenault, B. J., Guérin, R., et al. (2021) · Epigenomics · doi:10.2217/epi-2020-0456 · Cited by 8
Metabolic-Related Index to Predict Post-Transplantation Diabetes Mellitus After Kidney Transplantation
Ni, X., Chen, B., Yongling, L., Tingting, H., Zhou, Y., & Chen, Z. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2053-2688 · Cited by 7
Effect of interactive exergame training on physical fitness and executive function among men with substance use disorder in rehabilitation center
Guo, J., Zhang, L., Zhang, L., Li, Y., Yang, S., Sun, Y., Zhang, R., & Zhu, W. (2024) · Mental health and physical activity · doi:10.1016/j.mhpa.2024.100598 · Cited by 7
Association between hs-CRP/HDL with type 2 diabetes mellitus in middle-aged and elderly people: a cross-sectional study from CHARLS
Jiang, Y., & Yu, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1471292 · Cited by 7
Association of serum Metrnl levels and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus: a cross-sectional study
Zhou, C., Zeng, J., Gao, X., Chen, D., Zhu, Q., Feng, B., & Song, J. H. (2024) · PeerJ · doi:10.7717/peerj.18264 · Cited by 7
Integrative Analyses Reveal Tstd1 as a Potential Modulator of HDL Cholesterol and Mitochondrial Function in Mice
Zheng, A., Li, H., Feng, Z., & Liu, J. (2021) · Cells · doi:10.3390/cells10112976 · Cited by 7
Association of cluster determinant 36, scavenger receptor class B type 1, and major facilitator superfamily domain containing the 2a genetic polymorphism with serum lipid profile in aging population with type 2 diabetes mellitus
Wang, X., Ma, X., Xu, J., Guo, Y., Zhou, S., Yu, H., & Yuan, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.981200 · Cited by 7
Differential impact of glycation on apolipoprotein A-I of high-density lipoprotein: a review
Maarfi, F., Ahmad, S., Alouffi, S., Akasha, R., Khan, M. S., Rafi, Z., Basnet, H., & Khan, M. Y. (2023) · Glycobiology · doi:10.1093/glycob/cwad010 · Cited by 7
Association between atherogenic index of plasma and type 2 diabetes in women with a history of gestational diabetes mellitus: a cross-sectional study
Sheng, Y., Cun, D., Chen, Y., Hu, X.-J., Zhang, X., Sun, X., & Song, S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01914-2 · Cited by 6
Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?
Nicholls, S. J., Tan, S., Butters, J., & Nelson, A. J. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2409324 · Cited by 6
High-density lipoprotein and cardiac glucose metabolism: Implications for management of acute coronary syndromes
Richart, A. L., Heywood, S. E., Siebel, A. L., & Kingwell, B. A. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317748217 · Cited by 6
Self-citation
Genetic obesity increases pancreatic expression of mitochondrial proteins which regulate cholesterol efflux in BRIN-BD11 insulinoma cells
Caridis, A.-M., Lightbody, R. J., Tarlton, J., Dolan, S., & Graham, A. (2019) · Bioscience Reports · doi:10.1042/bsr20181155 · Cited by 6
Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents
Cheng, P., Sun, H.-Y., Feng, I., Chiu, Y., Wang, S.-T., Tan, D. C., Chiu, H., Chien, S.-C., & Young, K.-C. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.06.004 · Cited by 5
Associations of apolipoproteinA1, high density lipoprotein cholesterol with hemoglobin glycation index and triglyceride-glucose index in Chinese adults with coronary artery disease
Dong, H., Wang, J., Hu, P. F., & Lu, N. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108516 · Cited by 5
Metabolic syndrome—definition
Gargari, P., & Chatterjee, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00044-x · Cited by 5
Old HDL learns a new (anti-inflammatory) trick
Odegaard, J. I., & Chawla, A. (2014) · Nature Immunology · doi:10.1038/ni.2798 · Cited by 5
Does plasma HDL-C concentration interact with whole-body cholesterol metabolism?
Leança, C. C., Nunes, V. S., Nakandakare, E. R., de Faria, E. C., & Quintão, E. C. R. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.12.003 · Cited by 5
Apolipoprotein A-I stimulates secretion of insulin and matrix metalloproteinases by islets of Langerhans
Федорович, У. И., Poteryaeva, O. N., Русских, Г. С., Zubova, A., Boiko, K. Y., & Polyakov, L. M. (2018) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20186402195 · Cited by 5
HDLs extract lipophilic drugs from cells
Zheng, A., Dubuis, G., Georgieva, M., Ferreira, C. S. M., Serulla, M., Rubio, M. D. C. C., Trofimenko, E., Mercier, T., Decosterd, L. A., & Widmann, C. (2022) · Journal of Cell Science · doi:10.1242/jcs.258644 · Cited by 5
The Role of Pro-Opiomelanocortin Derivatives in the Development of Type 2 Diabetes-Associated Myocardial Infarction: Possible Links with Prediabetes
Gumede, N. A.-C., & Khathi, A. (2024) · Biomedicines · doi:10.3390/biomedicines12020314 · Cited by 5
The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases
Babintseva, Y. D., Camont, L., Chapman, J., Lhomme, M., Карагодин, В. П., Kontush, A., & Orekhov, A. N. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh2016889111-118 · Cited by 5
The PI3K/Akt pathway is not a main driver in HDL-mediated cell protection
Zheng, A., Dubuis, G., Ferreira, C. S. M., Pétremand, J., Vanli, G., & Widmann, C. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109347 · Cited by 5
Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study
Sokooti, S., Flores-Guerrero, J. L., Heerspink, H. J. L., Garcia, E., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2021) · Diabetologia · doi:10.1007/s00125-021-05603-3 · Cited by 5
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with early onset type 2 diabetes with NAFLD: a cross-sectional study in China
Wu, N., Ni, Y., Huang, R., Wang, J., Li, M., Hu, H., Zhang, Y., Li, J., & Zhang, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1662125 · Cited by 4
Reopening Pandora’s box: Is there a role for HDL in breast cancer?
Sawada, M. I., Santana, M. B. S., Vancini, M. G., & Passarelli, M. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.001 · Cited by 4
CETP Inhibitors: Back With a New Target
Nicholls, S. J., Ray, K. K., Nelson, A. J., & Kastelein, J. J. P. (2026) · Circulation Research · doi:10.1161/circresaha.125.327271 · Cited by 4
Echo‐tracking evaluation of changes in common carotid artery wall elasticity after smoking cessation
Zhang, P., Guo, R., Wang, C., Xiao, D., Qin, H., & Zhang, L. (2018) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22669 · Cited by 4
Blood lipid profile, HbA1c, fasting glucose, and diabetes: a cohort study and a two-sample Mendelian randomization analysis
Lin, Y.-C., Tu, H., & Wang, T. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02209-x · Cited by 4
Association between area under the C‐peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients
Zhang, C., Ma, X., Lin, W., Xu, Q., Li, H., Xu, C., Hao, M., & Kuang, H. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14109 · Cited by 4
Association Between Nontraditional Lipid Profiles and the Risk of Type 2 Diabetes Mellitus in Chinese Adults With Hypertension: Findings From the China Hypertension Registry Study
Yu, T., Wang, T., Zhou, W., Zhu, L., Yu, C., Li, J., Bao, H., & Cheng, X. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14927 · Cited by 4
C-reactive protein to high-density lipoprotein cholesterol ratio: an independent risk factor for diabetic retinopathy in type 2 diabetes patients
Zhang, Y., Chen, G., Wang, W., & Jing, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1537707 · Cited by 4
Uric acid to high-density lipoprotein cholesterol ratio in association with adverse health outcomes in patients with chronic kidney disease
Lei, K., Hu, S., Zhang, Y., Wang, J., & Wang, J. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104161 · Cited by 4
Uncovering the role of apolipoprotein C-III in insulin resistance
Aguilar-Recarte, D., Palomer, X., & Vázquez‐Carrera, M. (2021) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2021.04.002 · Cited by 4
Prevalence of low high-density lipoproteins (HDL) cholesterol and its related factors in adult Palestinians: a cross-sectional study
Damiri, B., Dudin, B., Sharqiah, Q. M., Khlaif, H., Bsharat, R., & Amir, M. (2021) · Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal · doi:10.59049/2790-0231.1085 · Cited by 4
Hypertriglyceridemia is a dose-dependent risk factor for type 2 diabetes mellitus: a systematic review and meta-analysis
Havelda, L., Szalai, E. Á., Obeidat, M., Dobszai, D., Veres, D. S., Kói, T., Sipter, E., Váncsa, S., Hegyi, P. J., Bucur, M., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1710007 · Cited by 5
Lipoprotein Ratios: Correlations With Glycated Hemoglobin Among Type 2 Diabetes Mellitus Patients
Prabhat, L. N. U., Jagriti, L. N. U., Banerjee, A., Bansal, A., & Gogoi, J. B. (2024) · Cureus · doi:10.7759/cureus.53665 · Cited by 3

Authors: Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A.
Affiliations: Baker Heart and Diabetes Institute (AU)
The Heart Research Institute (AU)
The Alfred Hospital (AU)
Corresponding author: Kingwell, Bronwyn A.
ORCID: Drew, Brian G.
Rye, Kerry-Anne
Duffy, Stephen J.
Kingwell, Bronwyn A.
Venue: Nature Reviews Endocrinology
Publisher: Springer Science and Business Media LLC
Published: 2012-01-24
Volume: 8
Issue: 4
Pages: 237-245
ISSN: 1759-5029 (ISSN-L)
1759-5037
DOI: 10.1038/nrendo.2011.235
OpenAlex: W1982981124
Cited by: 307
References: 114
Citations by year: 2026: 14 · 2025: 33 · 2024: 36 · 2023: 29 · 2022: 24 · 2021: 23 · 2020: 16 · 2019: 18 · 2018: 14 · 2017: 22 · 2016: 19 · 2015: 15 · 2014: 21 · 2013: 16 · 2012: 6
FWCI: 2.55
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Endocrinology (publishedVersion)
PubMed (publishedVersion)
Funders: State Government of Victoria
National Health and Medical Research Council
National Medical Research Council
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: high-density lipoprotein, glucose metabolism, glucose homeostasis, type 2 diabetes, insulin secretion, AMPK, muscle glucose uptake, insulin sensitivity, CETP inhibitors, HDL-raising therapy, atherosclerosis, lipid removal
MeSH terms: Animals, Blood Glucose, Diabetes Mellitus, Type 2, Humans, Insulin, Lipoproteins, HDL, Cholesterol, HDL

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The emerging role of HDL in glucose metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks